MOUNTAIN VIEW, Calif., Aug. 6, 2013 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that management is scheduled to make an investor presentation at 2013 Wedbush Securities Life Sciences Management Access Conference at 3:40 pm EDT on Tuesday, August 13. The conference is being held August 13-14 at the Le Parker Meridien in New York City.
A live audio webcast of the presentation will be available in the Investors section of the IRIDEX website at http://www.iridex.com/.
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through both direct and independent sales forces and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the Company's website at http://www.iridex.com.
SOURCE IRIDEX Corporation
Jim Mackaness, CFO and COO, 650-940-4700, or Investors, Matt Clawson, Allen & Caron, 949-474-4300, matt@allencaron.com
